Business Description
Utah Medical Products Inc
NAICS : 339112
SIC : 3841
ISIN : US9174881089
Description
Financial Strength
9/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 314.81 | |||||
Equity-to-Asset | 0.95 | |||||
Debt-to-EBITDA | 0.01 | |||||
Interest Coverage | N/A | |||||
Piotroski F-Score | 5/9 | |||||
Altman Z-Score | 23.17 | |||||
Beneish M-Score | -3.18 | |||||
WACC vs ROIC |
Growth Rank
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 6.3 | |||||
3-Year EBITDA Growth Rate | 3.8 | |||||
3-Year EPS without NRI Growth Rate | 10 | |||||
3-Year FCF Growth Rate | 4.3 | |||||
3-Year Book Growth Rate | 7.8 |
Momentum Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 20.16 | |||||
9-Day RSI | 29.59 | |||||
14-Day RSI | 34.67 | |||||
6-1 Month Momentum % | -12.38 | |||||
12-1 Month Momentum % | -28.16 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 22.56 | |||||
Quick Ratio | 20.53 | |||||
Cash Ratio | 19.72 | |||||
Days Inventory | 174.18 | |||||
Days Sales Outstanding | 28.98 | |||||
Days Payable | 17.58 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Dividend Yield % | 1.81 | |||||
Dividend Payout Ratio | 0.26 | |||||
3-Year Dividend Growth Rate | 1.7 | |||||
Forward Dividend Yield % | 1.82 | |||||
5-Year Yield-on-Cost % | 1.89 | |||||
3-Year Average Share Buyback Ratio | 0.1 | |||||
Shareholder Yield % | 1.8 |
Profitability Rank
9/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 59.81 | |||||
Operating Margin % | 33.4 | |||||
Net Margin % | 33.12 | |||||
FCF Margin % | 43.09 | |||||
ROE % | 13.72 | |||||
ROA % | 12.82 | |||||
ROIC % | 34.46 | |||||
ROC (Joel Greenblatt) % | 87.17 | |||||
ROCE % | 13.47 | |||||
Years of Profitability over Past 10-Year | 10 |
GF Value Rank
10/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 14.42 | |||||
PE Ratio without NRI | 14.42 | |||||
Shiller PE Ratio | 15.33 | |||||
Price-to-Owner-Earnings | 13.88 | |||||
PEG Ratio | 4.65 | |||||
PS Ratio | 4.76 | |||||
PB Ratio | 1.86 | |||||
Price-to-Tangible-Book | 2.18 | |||||
Price-to-Free-Cash-Flow | 11.06 | |||||
Price-to-Operating-Cash-Flow | 10.76 | |||||
EV-to-EBIT | 8.66 | |||||
EV-to-EBITDA | 6.28 | |||||
EV-to-Revenue | 2.89 | |||||
EV-to-FCF | 6.72 | |||||
Price-to-Projected-FCF | 0.93 | |||||
Price-to-DCF (Earnings Based) | 1.25 | |||||
Price-to-DCF (FCF Based) | 0.96 | |||||
Price-to-Median-PS-Value | 0.72 | |||||
Price-to-Graham-Number | 1.18 | |||||
Price-to-Net-Current-Asset-Value | 2.41 | |||||
Price-to-Net-Cash | 2.79 | |||||
Earnings Yield (Greenblatt) % | 11.55 | |||||
FCF Yield % | 9.15 | |||||
Forward Rate of Return (Yacktman) % | 11.19 |